Furie, R., Stohl, W., Ginzler, E. M., Becker, M., Mishra, N., Chatham, W., . . . Freimuth, W. (2008). Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: A phase I trial in patients with systemic lupus erythematosus. BioMed Central.
Chicago-стиль цитированияFurie, Richard, et al. Biologic Activity and Safety of Belimumab, a Neutralizing Anti-B-lymphocyte Stimulator (BLyS) Monoclonal Antibody: A Phase I Trial in Patients With Systemic Lupus Erythematosus. BioMed Central, 2008.
MLA-цитированиеFurie, Richard, et al. Biologic Activity and Safety of Belimumab, a Neutralizing Anti-B-lymphocyte Stimulator (BLyS) Monoclonal Antibody: A Phase I Trial in Patients With Systemic Lupus Erythematosus. BioMed Central, 2008.